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Abstract 
Background: Vitamin B12 deficiency is often diagnosed with hematological manifestations of megaloblastic macro-
cytic anemia, which is usually the initial presentation. Neurological symptoms are often considered to be late manifes-
tations and usually occur after the onset of anemia. Sub acute combined cord degeneration, which is a rare cause of 
myelopathy is however the commonest neurological manifestation of vitamin B12 deficiency.
Case presentation: We present a case of a 66 year old Sinhalese Sri Lankan female, who is a strict vegetarian, pre-
senting with one month’s history suggestive of Sub-acute combined cord degeneration in the absence of haema-
tological manifestations of anaemia. Her Serum B12 levels were significantly low, after which she was treated with 
hydroxycobalamine supplementation, showing marked clinical improvement of symptoms, with normalization of 
serum B12 levels. Hence, the diagnosis of vitamin B12 deficiency was confirmed retrospectively.
Conclusion: Vitamin B12 deficiency could rarely present with neurological manifestations in the absence of anaemia. 
Therefore a high index of suspicion is necessary for the early diagnosis and prompt treatment in order to reverse 
neurological manifestations, as the response to treatment is inversely proportionate to the severity and duration of 
the disease.
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Background
Vitamin B12 deficiency is usually associated with various 
hematological, gastrointestinal and neuropsychiatric dis-
orders [1]. Hematological manifestations include anemia 
with a macrocytic blood picture and megaloblastic bone 
marrow occurring rarely with the involvement of all three 
cell lines causing pancytopenia. According to studies 
which have been conducted in the past, anemia or hema-
tological impairment usually starts early and precedes 
[2] the neuro-psychiatric manifestations which are more 
serious, and delayed treatment may lead to permanent 
disability [3].
Neuropsychiatric manifestations include neuropathy, 
myelopathy, dementia, neuropsychiatric abnormali-
ties and rarely optic atrophy. Sub-acute combined cord 
degeneration (SACD) is the most frequent manifestation 
of vitamin B12 deficiency [4], but anemia is a common 
and leading symptom to the diagnosis of vitamin B12 defi-
ciency, and neurological manifestations typically occur 
after the onset of anemia [1, 5].
Case presentation
A 66 year old Sinhalese Sri Lankan lady, who had been a 
strict vegetarian for the past 20  years, presented to our 
teaching hospital with 1  month’s history of numbness 
and tingling of both lower limbs with unsteadiness of 
gait, without complaints of urinary or fecal incontinence. 
She had no fever, night sweats, gastrointestinal symptoms 
or any uremic symptoms. She did not have a history of 
pre-existing diabetes mellitus, hypertension or ischemic 
heart diseases or alcohol consumption. She did not show 
clinical or biochemical features of pernicious anemia.
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On examination, she was a thinly built lady with no 
hypo or hyperthyroid features. She had no pallor, icterus, 
peripheral edema or lymphadenopathy. Her pulse 
rate was 82 beats per minute with a blood pressure of 
130/78 mmHg. She did not have hepato-splenomegaly.
On neurological examination, she had stocking type 
sensory impairment up to mid shin level and absence 
of joint position and vibration sensation in both lower 
limbs. Her ankle jerks were absent bilaterally. Romberg’s 
sign and Babinski sign were positive, but had no impair-
ment of muscle power or tone. Her upper limbs, cranial 
nerves and higher functions were neurologically normal 
and had no cerebellar impairment.
Her laboratory investigations were unremarkable, with 
a hemoglobin concentration of 12.1  g/dl, red blood cell 
count of 4.39/mm3, mean corpuscular volume (MCV) 
of 83.3  fl, mean corpuscular hemoglobin concentration 
of 27.6  g/dl, platelet count of 334,000/mm3, serum cre-
atinine of 82  mg/dl, and normal fasting plasma glucose 
level sand thyroid stimulating hormone levels. Her blood 
picture revealed no features of vitamin B12 deficiency 
and showed normochromic normocytes. Demyelinating 
polyneuropathy was confirmed with nerve conduction 
studies.
Even though she did not have features of anemia, the 
clinical picture was suspicious of vitamin B12 deficiency 
and associated SACD. Hence we proceeded with the 
serum vitamin B12 levels, which was found to be very low; 
84.90  pg/ml (208–963). Thus, the clinical diagnosis of 
sub-acute combined cord degeneration due to deficiency 
of vitamin B12 without anemia was made.
She was treated with intramuscular hydroxycobalamine 
1000  μg for 7  days, weekly for 6  weeks and thereafter 
three monthly. After 3  months of replacement therapy, 
the patient showed clinical improvement, with repeated 
B12 levels being elevated up to 308.6  pg/ml. Follow up 
nerve conduction study done at 1 and 3  years showed 
previously absent Sural sensory nerve action potentials 
reappearing, and common peroneal and posterior tibial 
nerve conduction velocities being improved. This case 
demonstrates early clinical improvement, with slow 
recovery of polyneuropathy on nerve conduction studies, 
despite rapid correction of vitamin B12 levels following 
therapy with hydroxycobalamine.
Discussion
Vitamin B12 is a water-soluble vitamin found natu-
rally in meat and food of animal origin. Its physiologi-
cal functions include erythropoiesis, the synthesis and 
maintenance of myelin sheath and the synthesis of deox-
yribonucleic acid. The current recommended dietary 
allowance for vitamin B12 has been set by the Institute of 
Medicine at 2.4 μg per day for males and females aged 
14 years and above, with a serum level of vitamin B12 of 
120–180 pmol/l indicative of deficiency [6]. The mecha-
nisms that cause deficiency are malabsorption, malnutri-
tion or genetic deficiency of methylmalonyl-CoA mutase. 
Based on this case and considering malnutrition as the 
etiological factor, vegans who are not on vitamin B12 
supplements or fortified foods containing the vitamin 
are found to be at a higher risk of developing deficiency, 
compared to vegetarians [7].
B12 deficiency presents with hematological, gastro-
intestinal and neuropsychiatric manifestations. Neu-
ropsychiatric manifestations commonly associated with 
deficiency include myelopathy, neuropathy, dementia, 
neuropsychiatric abnormalities and rarely show optic 
nerve atrophy. SACD though a rare cause of myelopathy, 
is the most frequent clinical manifestation of B12 defi-
ciency [4]. The clinical signs of SACD typically include 
a spastic paraparesis, extensor plantar response, and 
impaired perception of position and vibration, and may 
have associated peripheral neuropathy which explains 
this patient’s stocking type numbness and absence of 
ankle jerks. Neuropathological lesions in SACD have 
been found to be due to overproduction of the myelino-
lytic Tumor necrosis factor α (TNFα) and to the reduced 
synthesis of the two neurotrophic agents; the Epidermal 
growth factor (EGF) and interleukin-6 caused by vitamin 
B12 deficiency [8]. Neuropathological studies, including 
T2 weighted Magnetic resonance imaging (MRI), show 
lesions classically involving the posterior and lateral col-
umns, predominantly in the upper thoracic and midtho-
racic regions, resulting in concomitant upper limb and 
lower limb involvement [9], in contrast to this case which 
has isolated lower limb involvement with normal upper 
limbs.
Neuropsychiatric manifestations include decreased 
memory, personality change, psychosis, emotional labil-
ity, and rarely delirium or coma, and may be seen in 
patients without haematological manifestations, or low 
normal B12 levels [5]. However this patient had no such 
psychiatric manifestations nor anaemia. Unusual neuro-
logical manifestations of the disease are cerebellar ataxia, 
leukoencephalopathy, orthostatic tremors, myoclonus, 
ophthalmoplegia, catatonia, vocal cord paralysis, a syrin-
gomyelia like distribution of motor and sensory deficits, 
and autonomic dysfunction [10] which were not seen in 
this case.
Anemia is a common and early symptom leading to 
the diagnosis of vitamin B12 deficiency, while as neu-
rological symptoms are often considered as late mani-
festations, and are typically preceded by anemia [5], 
unlike in this rare case of vitamin B12 deficiency with 
neurological manifestations in the absence of anaemia. 
However, haematological manifestations were found 
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to be associated with neuropsychiatric manifestations 
in only 28  % in a population study [5]. Approximately 
two-thirds of patients with vitamin B12 deficiency are 
shown to have hematological abnormalities charac-
terized by anemia, an elevated MCV, the presence of 
hypersegmented neutrophils and macrocytosis on 
peripheral blood smears [11]. A previous study has 
shown 10 % cases to have life threatening haematologi-
cal manifestations with 5 % having symptomatic pancy-
topenia [12].
Serum B12 level assessment is the mainstay of investi-
gation of vitamin B12 deficiency, whereas an increase in 
serum levels of methylmalonic acid and homocysteine 
also indicate the diagnosis [13]. Electrophysiological 
abnormalities include nerve conduction studies sug-
gestive of a sensorimotor axonopathy [14], as seen in 
this case. MRI of the cervical and dorsal spine shows 
increased T2 weighted signal intensity in the posterior 
and lateral columns of the cervical and upper thoracic 
spinal cord [15].
Once the diagnosis of vitamin B12 deficiency has been 
established, the goals of treatment are to reverse the 
signs and symptoms of deficiency, replenish body stores 
and ascertain the cause of deficiency while monitoring 
the response to therapy. Since the etiology in this case is 
obviously dietary deficiency, the mainstay of treatment 
is vitamin B12 supplementation. The recommended regi-
men is 1000 μg intramuscular injections for 5–7 days fol-
lowed by monthly 500–1000 μg intramuscular injections 
[16]. Response of the neurologic manifestations is varia-
ble and may be incomplete. They usually start around the 
first week, and is often complete within 6  months [17]. 
However, response to treatment is inversely proportional 
to the severity of deficiency, extent of involvement and 
the time lapsed between onset of symptoms and initia-
tion of therapy [18], indicating the importance of prompt 
diagnosis and treatment.
Conclusion
Vitamin B12 deficiency though commonly associated with 
haematological manifestations like macrocytic anaemia, 
it could rarely present with neurological manifestations 
in the absence of anaemia or macrocytosis. Therefore a 
high index of suspicion is necessary in early diagnosis 
and prompt treatment in order to reverse neurological 
manifestations, as the response to treatment is inversely 
proportional to the severity and duration of disease.
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